Curemark, LLC announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford.

Rye, NY (PRWEB) September 17, 2008 -- Curemark, LLC (www.cure-mark.com) announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford. This 5-day conference brings together some of the greatest research minds from around the world in the field of neurobiology both from academia and industry.

Dr. Fallon's paper, entitled, "The Role of a Dearth of Amino Acids in the Pathophysiology of Autism" details the groundbreaking discoveries regarding autism and its possible origins. This research is the focus of Curemark's plans for entering into clinical trials.

"It was an incredible honor to be among the most elite scientists in the world looking at the genetics of autism, Alzheimer's, Parkinson's disease and other neurodegenerative conditions." Commented Dr.Fallon, The Gordon Conferences are one of pre-eminent meetings in the world, and I am grateful that Curemark was able to be represented."

Present at the meeting were scientists from MIT, Harvard, Johns Hopkins, Oxford, Cambridge and other prestigious universities from around the world.

Curemark is a drug development company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of key enzymes in children with autism. The company is currently preparing for Clinical Trials. To learn more about Curemark's innovative science, visit www.cure-mark.com.

For more information, contact:

Alissa Minio

info @ cure-mark.com

(914) 925-3450

# # #

Simillar Articles

Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations

Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately.

Neuroscientists Will Meet in La Ciotat, France, to Talk About Applications of Basic Research to...

From Basic Research to Novel Treatment: Lost in Translation. Neuroscientists will meet in La Ciotat, France, to talk about applications of basic research to novel treatment of neurological diseases.

Curemark to Present at the 2008 Life Sciences & Healthcare Venture Summit 2008

Curemark announced today that it has been chosen to present at the 2008 Life Sciences and Healthcare Venture Summit October 30, 2008 to be held in New York City.

15th Annual International Society for Neurofeedback and Research Conference to be held in San...

The International Society for Neurofeedback and Research is holding its 15th annual conference in San Diego, CA September 6-9, 2007 at the beautiful Town and Country resort. The conference will...

LIA Foundation to Hold a New Jersey Conference on Lyme Disease and Autism

With autism at epidemic proportions and the new apparent linking of Lyme disease to autism, parents need answers and ways to help their children. The LIA Foundation is holding a conference on April...

Home